There are big markets and then there are big markets. While still miniscule, revenue wise, Vancouver's EnWave (TSXV:ENW) stands on the shoulders of … [Read more...] about Cantech Letter interviews Tim Durance of EnWave
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
All your eggs in one basket. Most investors know innately that this is a bad strategy. Investors into life sciences stocks, where half-decade long … [Read more...] about Cantech Letter interviews Howard Verrico, CEO of Sirona Biochem
Don Cherry and Ottawa Senators owner Eugene Melnyk teaming up? Not quite. While Don Cherry is still spokesman for Cold-FX, the most famous product of … [Read more...] about Valeant to acquire Afexa Life Sciences. A win, win, win situation?
When it comes to spending money, nobody does it quite like the biotech sector. The Texas Hold-Em style gamble of waiting to see if your particular … [Read more...] about Canada’s Biotech Stocks. Who’s got the Cash?
After a tough few years, 2011 is shaping up quite nicely for shareholders of Quebec City's Aeterna Zentaris (TSX:AEZ). Today, nearly eight years … [Read more...] about Eight is Enough for AEterna Zentaris; granted European patent for Perifosine
Things are changing quickly in the world of fish-farming. For proof you need look no further than the man voted "Canada's most trusted Canadian" in a … [Read more...] about 5 Questions with Richard Buchanan of Agrimarine (TSXV:FSH)
Shareholders of Toronto's Bioexx (TSX:BXI) are having the kind of day that has become all too familiar to them. The stock, which was down more than … [Read more...] about Is Bioexx ready to rebound?
A step closer. Quebec City's Medicago (TSX:MDG) today announced results from a phase I human trial that showed its H1N1 vaccine is safe. A hundred … [Read more...] about Medicago: Life in the Fast Lane
Shares of Resverlogix (TSX:RVX) are sliding today after the company announced it will raise $12.6 million. The Calgary based biotech will sell seven … [Read more...] about Resverlogix Slides on Financing News
Ask investors to play the word association game with Noveko (TSX:EKO) and it won't be long before the words swine flu show up. The Montreal company … [Read more...] about Is Noveko set to cash in on the “green building” movement?